|
| 37725924 | Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants. | Clin Chem | 2024 |
| 36343017 | Polygenic risk scores for prediction of breast cancer in Korean women. | Int J Epidemiol | 2023 |
| 37790698 | Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls. | Front Genet | 2023 |
| 37945903 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Nat Genet | 2023 |
| 37945903 | Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Nat Genet | 2023 |
| 37612283 | Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects. | Nat Commun | 2023 |
| 37503126 | Understanding the genetic complexity of puberty timing across the allele frequency spectrum. | medRxiv | 2023 |
| 37733366 | Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer. | JAMA Oncol | 2023 |
| 37292833 | Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry. | medRxiv | 2023 |
| 37451831 | Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. | J Med Genet | 2023 |
| 37311464 | Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry. | Am J Hum Genet | 2023 |
| 37444426 | Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. | Cancers (Basel) | 2023 |
| 37243694 | Prediction of breast cancer risk for sisters of women attending screening. | J Natl Cancer Inst | 2023 |
| 37178709 | Polygenic risk scores in cancer screening: a glass half full or half empty? | Lancet Oncol | 2023 |
| 37308304 | Exploring the barriers to and facilitators of implementing CanRisk in primary care: a qualitative thematic framework analysis. | Br J Gen Pract | 2023 |
| 37338730 | Evaluation of SNPs associated with mammographic density in European women with mammographic density in Asian women from South-East Asia. | Breast Cancer Res Treat | 2023 |
| 36649146 | Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36689693 | Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival. | J Clin Oncol | 2023 |
| 36872133 | Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. | Eur Urol | 2023 |
| 36641897 | EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy. | Eur J Cancer | 2023 |
| 36737659 | Proactive breast cancer risk assessment in primary care: a review based on the principles of screening. | Br J Cancer | 2023 |
| 36707629 | FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. | Eur J Hum Genet | 2023 |
| 36528478 | Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. | Eur Urol | 2023 |
| 36493335 | CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer. | J Clin Oncol | 2023 |
| 36493335 | CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer. | J Clin Oncol | 2023 |
| 36018819 | Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men. | Hum Mol Genet | 2023 |
| 34320204 | Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. | J Natl Cancer Inst | 2022 |
| 35654374 | Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35585550 | Breast cancer risks associated with missense variants in breast cancer susceptibility genes. | Genome Med | 2022 |
| 35543923 | Relevance of the MHC region for breast cancer susceptibility in Asians. | Breast Cancer | 2022 |
| 35723569 | Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies. | J Natl Cancer Inst | 2022 |
| 35418701 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. | Sci Rep | 2022 |
| 35716007 | Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants. | J Pathol | 2022 |
| 35554533 | Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach. | Hum Mol Genet | 2022 |
| 36419099 | Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated inâ¿¿~â¿¿200,000 patients. | Breast Cancer Res | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 36206742 | Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk prediction. | Am J Hum Genet | 2022 |
| 35933885 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model. | Eur J Cancer | 2022 |
| 36271417 | PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~â¿¿200,000 patients. | Breast Cancer Res | 2022 |
| 36303815 | A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women. | Cancer Res Commun | 2022 |
| 36328784 | Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. | Br J Sports Med | 2022 |
| 36356581 | Genome- and transcriptome-wide association studies of 386,000 Asian and European-ancestry women provide new insights into breast cancer genetics. | Am J Hum Genet | 2022 |
| 36162851 | Enhancing the BOADICEA cancer risk prediction model to incorporate new data on <i>RAD51C</i>, <i>RAD51D</i>, <i>BARD1</i> updates to tumour pathology and cancer incidence. | J Med Genet | 2022 |
| 36162852 | Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study. | J Med Genet | 2022 |
| 33811135 | Characterisation of protein-truncating and missense variants in <i>PALB2</i> in 15 768 women from Malaysia and Singapore. | J Med Genet | 2022 |
| 35157032 | Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer. | Hum Mol Genet | 2022 |
| 35042965 | Rare germline copy number variants (CNVs) and breast cancer risk. | Commun Biol | 2022 |
| 34906514 | Polygenic risk scores for prediction of breast cancer risk in Asian populations. | Genet Med | 2022 |
| 35143328 | Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast Cancer. | J Clin Oncol | 2022 |
| 35084436 | Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. | JAMA Oncol | 2022 |